에서 이용할 수 있어요!
자세히 알아보기
Supernus
SUPN
SUPN
소개: Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
직원 수: 778
뉴스
긍정적
중립
부정적
투자 심리
3개월
긍정적
52.9%
중립
41.2%
부정적
5.9%
가격 차트는 Lightweight Charts™ 라이브러리로 구현했어요